Latest Balance Sheet News

Temple & Webster has delivered its most profitable April ever with EBITDA hitting around $2.5 million, setting the stage for a near doubling of earnings in FY27 despite weak consumer confidence.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

Brookside Energy has captured over 40% of its targeted Riverbend acreage in Oklahoma, advancing its development plans to expand its Anadarko Basin footprint and drilling inventory.

Aristocrat Leisure delivered a strong half-year profit surge with 16% growth in normalised NPATA on a constant currency basis, driven by market share gains and strategic investments, while declaring a 50c interim dividend.

Catalyst Metals reports a 75% expansion of the high-grade underground gold zone at Cinnamon, challenging existing geological models and supporting plans for increased production from the Plutonic Gold Belt.

Genmin has drawn strong international interest to finance its Baniaka iron ore project in Gabon, with proposals ranging from joint ventures to prepayment facilities. The Gabonese government backs the project as a national priority, aiming for a final investment decision by mid-2026.

Commonwealth Bank of Australia reported a steady cash profit of around $2.7 billion in 3Q26, balancing disciplined lending growth and cautious provisioning amid geopolitical and economic uncertainties.

Zimi Limited has increased its placement commitments by A$100,000 from a sophisticated investor, bringing total funds raised to A$1.56 million ahead of shareholder approval.

Diablo Resources has completed the first tranche of a placement, raising $764,400 through 58.8 million shares at 1.3 cents each, with a shareholder meeting planned in June to approve a further $2.7 million raise.

The Asian Development Bank ramped up its commitments to $29.3 billion in 2025, driving private sector growth, regional cooperation, and climate resilience across Asia and the Pacific.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

Magontec Limited reported a robust first quarter in 2026, with gross profit surging 63% and metals sales volumes up 58%, driven by margin improvements and strategic expansion in electronic anodes and magnesium alloys.